Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-10

FDA Approved: NALOXONE HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s original application for naloxone hydrochloride, a generic product intended to reverse opioid overdose. The approv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

ORIG AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)